K223305 is an FDA 510(k) clearance for the Trevo NXT ProVue Retriever. This device is classified as a Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (Class II - Special Controls, product code POL).
Submitted by Stryker Neurovascular (Fremont, US). The FDA issued a Cleared decision on March 29, 2023, 153 days after receiving the submission on October 27, 2022.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5600. A Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment Is A Prescription Device Used In The Treatment Of Acute Ischemic Stroke To Improve Clinical Outcomes. The Device Is Delivered Into The Neurovasculature With An Endovascular Approach, Mechanically Removes Thrombus From The Body, And Restores Blood Flow In The Neurovasculature..
| 510(k) Number | K223305 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | October 27, 2022 |
| Decision Date | March 29, 2023 |
| Days to Decision | 153 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | POL — Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 882.5600 |
| Definition | A Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment Is A Prescription Device Used In The Treatment Of Acute Ischemic Stroke To Improve Clinical Outcomes. The Device Is Delivered Into The Neurovasculature With An Endovascular Approach, Mechanically Removes Thrombus From The Body, And Restores Blood Flow In The Neurovasculature. |